St. Jude Medical (STJ) Reports In-Line Q2 EPS of $0.63; Authorizes $500M Buyback; Guides Q3, FY09
Tweet Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ) reports Q2 EPS of $0.63, inline with the analyst estimate of $0.63. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
